Physician

Lina M Ya'Qoub, MD

According to 2025 Medicare claims, Lina Ya'Qoub, MD (NPI: 1578940862) practices cardiology in the Merced, CA market, with the plurality of this provider's patient population coming from Merced, CA. This provider's primary affiliated billing organization is CENTRAL VALLEY CARDIOVASCULAR MEDICAL GROUP, INC (NPI: 1962750224; TIN: 010961637) and primary practice location at 95382-2016.

Ya'Qoub's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 691 traditional Medicare patients, billed 2,321 HCPCS/CPT codes, and received $204,256 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,896 prescription claims across 290 beneficiaries totaling $182,629 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 120 records totaling $12,342. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,934 and ending at $182,629. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$102K$204K2023 Medicare payment: $108,455 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $204,256 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
20233651,207$108,455
20246912,321$204,256

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$91K$183K2015 Drug cost: $1,934 (USD; Tot_Drug_Cst)2016 Drug cost: $36,656 (USD; Tot_Drug_Cst)2017 Drug cost: $45,696 (USD; Tot_Drug_Cst)2018 Drug cost: $23,353 (USD; Tot_Drug_Cst)2019 Drug cost: $3,490 (USD; Tot_Drug_Cst)2020 Drug cost: $15,616 (USD; Tot_Drug_Cst)2021 Drug cost: $8,868 (USD; Tot_Drug_Cst)2022 Drug cost: $4,680 (USD; Tot_Drug_Cst)2023 Drug cost: $36,546 (USD; Tot_Drug_Cst)2024 Drug cost: $182,629 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151251$1,934
201685433$36,656
201786665$45,696
201866408$23,353
201936129$3,490
202046199$15,616
202140149$8,868
20222261$4,680
2023134395$36,546
20242901,896$182,629

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more135213$91
93306Ultrasound of heart with color-depicted blood flow, rate, direction and valve function235250$43
93016Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician123123$14
99152Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes144161$9
93010Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only156194$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EliquisApixaban984,452$85,064
JardianceEmpagliflozin281,477$27,474
Atorvastatin CalciumAtorvastatin Calcium21914,714$3,141
ClopidogrelClopidogrel Bisulfate16410,979$1,911
Ranolazine ErRanolazine14660$1,273

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.120$12,342Abbott Laboratories
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Lina M. Ya'Qoub, MD?

Tedicare shows public-source Medicare data for Lina M. Ya'Qoub, MD (NPI 1578940862), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Lina M. Ya'Qoub, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Lina M. Ya'Qoub, MD?

Lina M. Ya'Qoub, MD is linked to CENTRAL VALLEY CARDIOVASCULAR MEDICAL GROUP, INC (billing NPI 1962750224) in the available physician profile data.

Does Lina M. Ya'Qoub, MD have Open Payments data?

Lina M. Ya'Qoub, MD has 120 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.